Explore
Screen US SEC filers on the fundamentals they reported — without an account. Every figure links back to the filing it came from.
Cash-flow-statement, debt and leverage columns beside the balance sheet, sorted by net cash from operating activities (descending, absences last). Every populated cell carries the accession number of the filing that reported it; nothing here is annualised.
5,670 of 6,352 filers · 16 of 51 columns shown · as of 2026-09-11 · SEC EDGAR XBRL frames, public domain · show all 51
Showing 351–400 of 5,670 matching filers · page 8 of 114 · 50 rows per page · sorted by operatingCashFlow (ascending, absences last)
| Ticker | Company | Sector | Exchange | Period end | net cash from operating activities | net cash from investing activities | net cash from financing activities | capital expenditure (payments to acquire PP&E) | depreciation, depletion and amortisation | net income (loss) | revenues | total assets | total liabilities | stockholders' equity | long-term debt, non-current | long-term debt, current portion | cash and cash equivalents | liabilities / assets | current ratio | return on assets |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FPH | Five Point Holdings, LLC | Finance, Insurance and Real Estate | NYSE | 2026-06-30 | -$44.5M | -$281K | -$48.2M | $0 | $1.7M | $10.9M | $13.9M | $3.2B | $814.9M | no data: the filer did not report StockholdersEquity in the frame this panel covers | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $348.4M | 25.3% | no data: not derivable: MISSING_INPUT | 0.3% |
| TNGX | Tango Therapeutics, Inc. | Manufacturing | Nasdaq | 2026-08-04 | -$44.4M | $9.6M | $79.8M | -$2K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$55.3M | $0 | $1.1B | $49.3M | $1B | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $345.6M | 4.6% | 50.82× | -5.2% |
| NKTR | NEKTAR THERAPEUTICS | Manufacturing | Nasdaq | 2026-08-07 | -$44.3M | -$350.8M | $529.5M | $18K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$40.6M | no data: the filer did not report Revenues in the frame this panel covers | $1.1B | $192M | $903.1M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $39.3M | 17.5% | 10.42× | -3.7% |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | Manufacturing | Nasdaq | 2026-08-01 | -$44.2M | $57.1M | -$5.4M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$49.3M | no data: the filer did not report Revenues in the frame this panel covers | $437.3M | $220M | $103M | $93.4M | $7.3M | $65.6M | 50.3% | 3.45× | -11.3% |
| CC | Chemours Co | Manufacturing | NYSE | 2026-07-30 | -$44M | -$44M | -$19M | $49M | $79M | -$274M | no data: the filer did not report Revenues in the frame this panel covers | $7.2B | $7.2B | -$49M | $3.8B | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $671M | 100.7% | 1.66× | -3.8% |
| PGEN | PRECIGEN, INC. | Manufacturing | Nasdaq | 2026-07-31 | -$43.8M | $21M | $109K | $258K | $1.1M | $20.1M | no data: the filer did not report Revenues in the frame this panel covers | $170.3M | $126.7M | $43.6M | $93.9M | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $16.3M | 74.4% | 4.58× | 11.8% |
| FLS | FLOWSERVE CORP | Manufacturing | NYSE | 2026-07-21 | -$43.1M | -$7.2M | $88.5M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | $24.1M | $99M | $0 | $6.3B | no data: the filer did not report Liabilities in the frame this panel covers | $2.3B | $2.1B | $49.9M | no data: the filer did not report CashAndCashEquivalentsAtCarryingValue in the frame this panel covers | no data: not derivable: MISSING_INPUT | 2.15× | 1.6% |
| PRME | Prime Medicine, Inc. | Manufacturing | Nasdaq | 2026-07-31 | -$42.7M | $43.4M | $393K | $214K | $1.9M | -$42.1M | no data: the filer did not report Revenues in the frame this panel covers | $249M | $209.2M | $39.8M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $47.5M | 84.0% | 3.05× | -16.9% |
| PCT | PureCycle Technologies, Inc. | Manufacturing | Nasdaq | 2026-08-04 | -$42.7M | -$20.7M | -$4.6M | $3.4M | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$142.2M | $4.5M | $1B | $671.6M | $15.5M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $165.2M | 67.0% | 2.60× | -14.2% |
| DFTX | Definium Therapeutics, Inc. | Manufacturing | Nasdaq | 2026-07-30 | -$42.6M | $42M | $5.3M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$159M | no data: the filer did not report Revenues in the frame this panel covers | $1.1B | $194.2M | $918.7M | $36.5M | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $655.3M | 17.5% | 6.95× | -14.3% |
| CABA | Cabaletta Bio, Inc. | Manufacturing | Nasdaq | 2026-08-07 | -$42.6M | $51M | $25.3M | $0 | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$51M | no data: the filer did not report Revenues in the frame this panel covers | $256.7M | $46.1M | $210.6M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $225.1M | 18.0% | 5.79× | -19.9% |
| EWTX | Edgewise Therapeutics, Inc. | Manufacturing | Nasdaq | 2026-07-31 | -$42.5M | $2.4M | $12.2M | $260K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$57.3M | no data: the filer did not report Revenues in the frame this panel covers | $479.7M | $31.6M | $448.1M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $72.3M | 6.6% | 16.24× | -12.0% |
| ABTC | American Bitcoin Corp. | Finance, Insurance and Real Estate | Nasdaq | 2026-06-30 | -$42.5M | -$61.8M | $110.5M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$57.2M | $67M | $1.3B | $637.4M | $672.1M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | no data: the filer did not report CashAndCashEquivalentsAtCarryingValue in the frame this panel covers | 48.7% | 0.19× | -4.4% |
| TNXP | Tonix Pharmaceuticals Holding Corp. | Manufacturing | Nasdaq | 2026-08-07 | -$42.3M | -$1.7M | $20.2M | $1.7M | $555K | -$40.6M | no data: the filer did not report Revenues in the frame this panel covers | $254.1M | $31.8M | $222.3M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $176.2M | 12.5% | 6.61× | -16.0% |
| IE | Ivanhoe Electric Inc. | Mining | NYSE | 2026-08-07 | -$42.3M | $115.2M | $43M | $597K | $564K | -$24.7M | no data: the filer did not report Revenues in the frame this panel covers | $584.8M | $54.2M | $525.8M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $256.9M | 9.3% | 5.05× | -4.2% |
| STRO | SUTRO BIOPHARMA, INC. | Manufacturing | Nasdaq | 2026-08-07 | -$42.3M | -$45.3M | $103.1M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | $1.3M | -$38.5M | no data: the filer did not report Revenues in the frame this panel covers | $194.5M | $297.8M | -$103.3M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $54.3M | 153.1% | 3.32× | -19.8% |
| HRZN | Horizon Technology Finance Corp | no data: filer reported no SIC code in its EDGAR submission header | Nasdaq | 2026-08-04 | -$42.1M | no data: the filer did not report NetCashProvidedByUsedInInvestingActivities in the frame this panel covers | -$27.3M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$37.3M | no data: the filer did not report Revenues in the frame this panel covers | $832M | $414.5M | $417.5M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | no data: the filer did not report CashAndCashEquivalentsAtCarryingValue in the frame this panel covers | 49.8% | no data: not derivable: MISSING_INPUT | -4.5% |
| SMP | STANDARD MOTOR PRODUCTS, INC. | Manufacturing | NYSE | 2026-07-31 | -$41.9M | -$6.7M | $35.8M | $6.7M | $11.3M | $30.4M | no data: the filer did not report Revenues in the frame this panel covers | $2.1B | $1.3B | $717.7M | $534.2M | $52M | no data: the filer did not report CashAndCashEquivalentsAtCarryingValue in the frame this panel covers | 64.5% | 2.00× | 1.5% |
| AVBP | ArriVent BioPharma, Inc. | Manufacturing | Nasdaq | 2026-08-10 | -$41.9M | $3.6M | $54.9M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$49.9M | no data: the filer did not report Revenues in the frame this panel covers | $394.7M | $27.9M | $366.8M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $154.7M | 7.1% | 14.16× | -12.6% |
| IVVD | Invivyd, Inc. | Manufacturing | Nasdaq | 2026-07-30 | -$41.7M | -$726K | -$98K | $726K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$44.4M | $14.3M | $218.9M | $37.8M | $181.1M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $160.1M | 17.3% | 5.87× | -20.3% |
| TRDA | Entrada Therapeutics, Inc. | Manufacturing | Nasdaq | 2026-07-31 | -$41.7M | $27M | $100K | $44K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$42.8M | no data: the filer did not report Revenues in the frame this panel covers | $298.9M | $65.5M | $233.4M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $99.3M | 21.9% | 10.89× | -14.3% |
| PROK | PROKIDNEY CORP. | Manufacturing | Nasdaq | 2026-06-30 | -$41.7M | $34.8M | $215K | $3.8M | $1.7M | -$28.4M | no data: the filer did not report Revenues in the frame this panel covers | $249M | $26.2M | -$883.5M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $74.9M | 10.5% | 8.36× | -11.4% |
| KYTX | Kyverna Therapeutics, Inc. | Manufacturing | Nasdaq | 2026-08-03 | -$41.6M | -$50.2M | -$101K | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | $351K | -$38.3M | no data: the filer did not report Revenues in the frame this panel covers | $219.8M | $54.3M | $165.5M | $24.9M | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $31.8M | 24.7% | 9.06× | -17.4% |
| BTCW | WisdomTree Bitcoin Fund | Finance, Insurance and Real Estate | CBOE | 2026-06-30 | -$41.5M | no data: the filer did not report NetCashProvidedByUsedInInvestingActivities in the frame this panel covers | $41.5M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | no data: the filer did not report NetIncomeLoss in the frame this panel covers | no data: the filer did not report Revenues in the frame this panel covers | $136.5M | $29.4K | no data: the filer did not report StockholdersEquity in the frame this panel covers | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | no data: the filer did not report CashAndCashEquivalentsAtCarryingValue in the frame this panel covers | 0.0% | no data: not derivable: MISSING_INPUT | no data: not derivable: MISSING_INPUT |
| SHLS | Shoals Technologies Group, Inc. | Manufacturing | Nasdaq | 2026-06-30 | -$41.4M | -$7.6M | $43.7M | $7.6M | $4.1M | $12.1M | no data: the filer did not report Revenues in the frame this panel covers | $1B | $399.7M | $617.2M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $15.7M | 39.3% | 2.25× | 1.2% |
| SERV | Serve Robotics Inc. /DE/ | Manufacturing | Nasdaq | 2026-08-04 | -$41.4M | -$19.6M | $1.9M | $1.4M | $6.3M | -$64.1M | no data: the filer did not report Revenues in the frame this panel covers | $378.6M | $26.8M | $351.8M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $79.1M | 7.1% | 12.83× | -16.9% |
| ROCK | GIBRALTAR INDUSTRIES, INC. | Manufacturing | Nasdaq | 2026-08-03 | -$41.2M | -$1.3B | $1.2B | $6M | $15.9M | $8.2M | $509.5M | $2.8B | no data: the filer did not report Liabilities in the frame this panel covers | $890.8M | $1.2B | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $15.1M | no data: not derivable: MISSING_INPUT | 1.46× | 0.3% |
| ODTX | Odyssey Therapeutics, Inc. | Manufacturing | Nasdaq | 2026-06-30 | -$41M | $34.8M | $484K | $148K | $1.2M | -$52.8M | no data: the filer did not report Revenues in the frame this panel covers | $483.9M | $62.6M | $421.2M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $82M | 12.9% | 11.36× | -10.9% |
| CODQL | Coronado Global Resources Inc. | Mining | OTC | 2026-07-31 | -$40.9M | -$35M | $23.6M | $34.1M | $43.3M | no data: the filer did not report NetIncomeLoss in the frame this panel covers | $514.1M | $2.3B | $2.1B | no data: the filer did not report StockholdersEquity in the frame this panel covers | $692.8M | $1.7M | no data: the filer did not report CashAndCashEquivalentsAtCarryingValue in the frame this panel covers | 90.2% | 1.18× | no data: not derivable: MISSING_INPUT |
| TSHA | Taysha Gene Therapies, Inc. | Manufacturing | Nasdaq | 2026-08-11 | -$40.9M | -$3M | $711K | $24K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$46.6M | $0 | $470.4M | $83.2M | $387.3M | $49.3M | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $455.4M | 17.7% | 17.76× | -9.9% |
| FELE | FRANKLIN ELECTRIC CO INC | Manufacturing | Nasdaq | 2026-07-23 | -$40.9M | -$9.5M | $32.6M | $9.5M | $16.5M | $65.7M | no data: the filer did not report Revenues in the frame this panel covers | $2.2B | no data: the filer did not report Liabilities in the frame this panel covers | $1.4B | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $97.3M | no data: not derivable: MISSING_INPUT | 2.41× | 3.1% |
| PARR | PAR PACIFIC HOLDINGS, INC. | Mining | NYSE | 2026-07-30 | -$40.7M | -$43.1M | $91.8M | $43.1M | $34.5M | $462.1M | no data: the filer did not report Revenues in the frame this panel covers | $4.5B | $2.5B | $2B | $738.2M | $4.9M | $185M | 55.5% | 1.84× | 10.2% |
| TVTX | Travere Therapeutics, Inc. | Manufacturing | Nasdaq | 2026-07-30 | -$40.4M | $21.5M | $4.2M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | $25.2M | -$34.8M | no data: the filer did not report Revenues in the frame this panel covers | $799.4M | $774.8M | $24.5M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $117.7M | 96.9% | 4.05× | -4.4% |
| KOD | Kodiak Sciences Inc. | Manufacturing | Nasdaq | 2026-08-06 | -$40M | -$942K | $619K | $942K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$65.6M | no data: the filer did not report Revenues in the frame this panel covers | $256.8M | $195.7M | $61.1M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $125.9M | 76.2% | 2.49× | -25.6% |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Manufacturing | NYSE | 2026-06-30 | -$40M | $229M | $13M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$576M | no data: the filer did not report Revenues in the frame this panel covers | $39.9B | $32.1B | $7.8B | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | $1.8B | $3.7B | 80.5% | 0.88× | -1.4% |
| DBRG | DigitalBridge Group, Inc. | Finance, Insurance and Real Estate | NYSE | 2026-07-31 | -$40M | $101.4M | -$38.6M | $146K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | $227.3M | $508.7M | $3.8B | $1.1B | $2.3B | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $508.2M | 29.7% | no data: not derivable: MISSING_INPUT | 6.0% |
| BTCO | Invesco Galaxy Bitcoin ETF | Finance, Insurance and Real Estate | CBOE | 2026-06-30 | -$39.9M | no data: the filer did not report NetCashProvidedByUsedInInvestingActivities in the frame this panel covers | $39.9M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$56.1M | no data: the filer did not report Revenues in the frame this panel covers | $315.9M | $80.8K | $315.8M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | no data: the filer did not report CashAndCashEquivalentsAtCarryingValue in the frame this panel covers | 0.0% | no data: not derivable: MISSING_INPUT | -17.8% |
| VOYG | Voyager Technologies, Inc./TX | Manufacturing | NYSE | 2026-06-30 | -$39.7M | -$32.9M | $10.7M | $51.1M | $6M | -$46.5M | no data: the filer did not report Revenues in the frame this panel covers | $1B | $632.7M | $325.7M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $373.4M | 62.7% | 3.80× | -4.6% |
| GPRE | Green Plains Inc. | Manufacturing | Nasdaq | 2026-08-03 | -$39.5M | -$4.4M | -$3M | $6.4M | $23.6M | $67.1M | $446.2M | $1.7B | $787.2M | $869.9M | $387.2M | $3.9M | $185.4M | 47.5% | 1.99× | 4.1% |
| MLYS | Mineralys Therapeutics, Inc. | Manufacturing | Nasdaq | 2026-08-03 | -$39.5M | -$44.9M | $24.3M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | $6K | -$241.1M | no data: the filer did not report Revenues in the frame this panel covers | $667.9M | $116.9M | $550.9M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $138.3M | 17.5% | 34.46× | -36.1% |
| EGY | VAALCO ENERGY INC /DE/ | Mining | NYSE | 2026-08-04 | -$39.2M | -$52.6M | $81M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | $42.4M | $135.2M | $968.6M | $588.2M | $380.3M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $30.4M | 60.7% | 0.44× | 4.4% |
| MAZE | Maze Therapeutics, Inc. | Manufacturing | Nasdaq | 2026-08-05 | -$39.1M | $6.3M | $42.4M | $93K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$44.7M | no data: the filer did not report Revenues in the frame this panel covers | $531.6M | $78.5M | $453.1M | $39M | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $202.6M | 14.8% | 18.31× | -8.4% |
| GOSS | Gossamer Bio, Inc. | Manufacturing | Nasdaq | 2026-08-08 | -$38.7M | $41.6M | $512K | $0 | $5K | $16.9M | no data: the filer did not report Revenues in the frame this panel covers | $76.9M | $170.9M | -$94M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $41.1M | 222.3% | 0.53× | 22.0% |
| TCBX | Third Coast Bancshares, Inc. | Finance, Insurance and Real Estate | NYSE | 2026-07-31 | -$38.7M | $25.7M | $263M | no data: the filer did not report PaymentsToAcquirePropertyPlantAndEquipment in the frame this panel covers | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | $22M | no data: the filer did not report Revenues in the frame this panel covers | $6.7B | $6.1B | $670.8M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $404.2M | 90.0% | no data: not derivable: MISSING_INPUT | 0.3% |
| LYEL | Lyell Immunopharma, Inc. | Manufacturing | Nasdaq | 2026-08-03 | -$38.5M | $17.4M | $51.7M | $89K | $2.3M | -$44.8M | $4K | $311.2M | $77.3M | $233.8M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $73M | 24.9% | 5.36× | -14.4% |
| VOR | Vor Biopharma Inc. | Manufacturing | Nasdaq | 2026-08-06 | -$38.2M | -$263.2M | $74.9M | $48K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$62.8M | no data: the filer did not report Revenues in the frame this panel covers | $481.1M | $681.3M | -$200.2M | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $107.9M | 141.6% | 19.15× | -13.1% |
| QURE | uniQure N.V. | Manufacturing | Nasdaq | 2026-07-24 | -$38.2M | $98.6M | $550K | $140K | no data: the filer did not report DepreciationDepletionAndAmortization in the frame this panel covers | -$81.1M | $5.8M | $985.1M | $661.1M | $324.1M | $50.1M | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $413M | 67.1% | 10.01× | -8.2% |
| PRCT | PROCEPT BioRobotics Corp | Manufacturing | Nasdaq | 2026-07-31 | -$38.1M | -$2.9M | $222K | $2.9M | $1.7M | -$26.9M | no data: the filer did not report Revenues in the frame this panel covers | $479.4M | $139.3M | $340.1M | $51.7M | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $227.9M | 29.1% | 6.55× | -5.6% |
| INBX | Inhibrx Biosciences, Inc. | Manufacturing | Nasdaq | 2026-08-07 | -$38M | $0 | $75.5M | $0 | $537K | -$36.7M | $0 | $154.2M | $207.2M | -$53M | $176.3M | no data: the filer did not report LongTermDebtCurrent in the frame this panel covers | $133.3M | 134.4% | 5.07× | -23.8% |
| LPX | LOUISIANA-PACIFIC CORP | Manufacturing | NYSE | 2026-07-31 | -$38M | -$61M | -$29M | $61M | $38M | $26M | $664M | $2.6B | $863M | $1.7B | no data: the filer did not report LongTermDebtNoncurrent in the frame this panel covers | $0 | $228M | 33.1% | 3.22× | 1.0% |
No price, volume or market cap
no public-domain source for US equity last-sale price or volume: exchange and vendor price feeds are licensed, and this anonymous surface serves only public-domain data (SEC EDGAR, FRED, Treasury, BLS, FINRA, CBOE historical, OCC).
market cap needs a last-sale price, and no public-domain US equity price source exists for this surface; shares outstanding alone is not a market cap, and neither is the SEC-reported public float served in the `publicFloat` column.
Notes measured on this load
- the SEC frames panel covers 6,352 CIKs, of which 682 have no ticker in SEC's company_tickers_exchange.json and are EXCLUDED from this ticker-keyed screener — they are filers the SEC published facts for, not rows that were dropped for being low quality
- operatingCashFlowMargin is derivable for ZERO filers on this pull: its inputs landed from different XBRL frames, and dividing one quarter by another quarter would be a ratio that describes no period — every row carries PERIOD_MISMATCH or MISSING_INPUT instead
- 6 of 44 columns are reported by fewer than 1,500 of the served filers; sorting on one ranks the filers that report it, not the universe — per-column counts are in `coverage`
Column provenance — check any figure yourself on data.sec.gov
Each populated cell's hover title carries the exact reported value, the tag, the period end and the accession number of the filing that reported it. Each column below names the XBRL frame its whole cross-section came from. Ratios are derived from these same reported facts under period-consistency rules: numerator and denominator must come from the same period, denominators must be positive, and nothing is annualised — an underivable ratio renders as an em-dash with its reason, never as a guess.
| Column | Concept | Frame | Unit | Reported by | Source |
|---|---|---|---|---|---|
| revenues | us-gaap:Revenues | CY2026Q2 | USD | 1,456 filers | data.sec.gov |
| revenue from contracts with customers (ex. assessed tax) | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | CY2026Q2 | USD | 2,206 filers | data.sec.gov |
| cost of goods and services sold | us-gaap:CostOfGoodsAndServicesSold | CY2026Q2 | USD | 1,255 filers | data.sec.gov |
| gross profit | us-gaap:GrossProfit | CY2026Q2 | USD | 1,740 filers | data.sec.gov |
| operating expenses | us-gaap:OperatingExpenses | CY2026Q2 | USD | 2,075 filers | data.sec.gov |
| research and development expense | us-gaap:ResearchAndDevelopmentExpense | CY2026Q2 | USD | 1,589 filers | data.sec.gov |
| selling, general and administrative expense | us-gaap:SellingGeneralAndAdministrativeExpense | CY2026Q2 | USD | 1,583 filers | data.sec.gov |
| operating income (loss) | us-gaap:OperatingIncomeLoss | CY2026Q2 | USD | 3,726 filers | data.sec.gov |
| non-operating income (expense) | us-gaap:NonoperatingIncomeExpense | CY2026Q2 | USD | 1,920 filers | data.sec.gov |
| pre-tax income from continuing operations | us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | CY2026Q2 | USD | 3,284 filers | data.sec.gov |
| income tax expense (benefit) | us-gaap:IncomeTaxExpenseBenefit | CY2026Q2 | USD | 3,408 filers | data.sec.gov |
| net income (loss) | us-gaap:NetIncomeLoss | CY2026Q2 | USD | 4,478 filers | data.sec.gov |
| earnings per share, basic (quarterly, as filed) | us-gaap:EarningsPerShareBasic | CY2026Q2 | USD/shares | 4,026 filers | data.sec.gov |
| earnings per share, diluted (quarterly, as filed) | us-gaap:EarningsPerShareDiluted | CY2026Q2 | USD/shares | 3,936 filers | data.sec.gov |
| weighted-average diluted shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | CY2026Q2 | shares | 3,987 filers | data.sec.gov |
| total assets | us-gaap:Assets | CY2026Q2I | USD | 4,834 filers | data.sec.gov |
| current assets | us-gaap:AssetsCurrent | CY2026Q2I | USD | 3,903 filers | data.sec.gov |
| cash and cash equivalents | us-gaap:CashAndCashEquivalentsAtCarryingValue | CY2026Q2I | USD | 3,793 filers | data.sec.gov |
| accounts receivable, net (current) | us-gaap:AccountsReceivableNetCurrent | CY2026Q1I | USD | 2,549 filers | data.sec.gov |
| inventory, net | us-gaap:InventoryNet | CY2026Q1I | USD | 2,076 filers | data.sec.gov |
| property, plant and equipment, net | us-gaap:PropertyPlantAndEquipmentNet | CY2026Q1I | USD | 3,464 filers | data.sec.gov |
| goodwill | us-gaap:Goodwill | CY2026Q2I | USD | 2,442 filers | data.sec.gov |
| intangible assets, net (excluding goodwill) | us-gaap:IntangibleAssetsNetExcludingGoodwill | CY2026Q1I | USD | 1,915 filers | data.sec.gov |
| total liabilities | us-gaap:Liabilities | CY2026Q2I | USD | 4,316 filers | data.sec.gov |
| current liabilities | us-gaap:LiabilitiesCurrent | CY2026Q2I | USD | 3,884 filers | data.sec.gov |
| accounts payable (current) | us-gaap:AccountsPayableCurrent | CY2026Q1I | USD | 2,974 filers | data.sec.gov |
| long-term debt, non-current | us-gaap:LongTermDebtNoncurrent | CY2026Q2I | USD | 1,411 filers | data.sec.gov |
| long-term debt, current portion | us-gaap:LongTermDebtCurrent | CY2025Q4I | USD | 1,333 filers | data.sec.gov |
| operating lease right-of-use asset | us-gaap:OperatingLeaseRightOfUseAsset | CY2025Q4I | USD | 4,085 filers | data.sec.gov |
| operating lease liability, current | us-gaap:OperatingLeaseLiabilityCurrent | CY2025Q4I | USD | 3,419 filers | data.sec.gov |
| operating lease liability, non-current | us-gaap:OperatingLeaseLiabilityNoncurrent | CY2025Q4I | USD | 3,361 filers | data.sec.gov |
| operating lease weighted-average discount rate (decimal fraction) | us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent | CY2025Q4I | pure | 3,440 filers | data.sec.gov |
| operating lease cost | us-gaap:OperatingLeaseCost | CY2026Q1 | USD | 1,256 filers | data.sec.gov |
| retained earnings (accumulated deficit) | us-gaap:RetainedEarningsAccumulatedDeficit | CY2026Q2I | USD | 4,619 filers | data.sec.gov |
| stockholders' equity | us-gaap:StockholdersEquity | CY2026Q2I | USD | 4,511 filers | data.sec.gov |
| net cash from operating activities | us-gaap:NetCashProvidedByUsedInOperatingActivities | CY2026Q1 | USD | 4,107 filers | data.sec.gov |
| net cash from investing activities | us-gaap:NetCashProvidedByUsedInInvestingActivities | CY2026Q1 | USD | 3,560 filers | data.sec.gov |
| net cash from financing activities | us-gaap:NetCashProvidedByUsedInFinancingActivities | CY2026Q1 | USD | 3,895 filers | data.sec.gov |
| capital expenditure (payments to acquire PP&E) | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | CY2026Q1 | USD | 2,354 filers | data.sec.gov |
| depreciation, depletion and amortisation | us-gaap:DepreciationDepletionAndAmortization | CY2026Q1 | USD | 1,979 filers | data.sec.gov |
| share-based compensation | us-gaap:ShareBasedCompensation | CY2026Q1 | USD | 3,130 filers | data.sec.gov |
| payments for repurchase of common stock | us-gaap:PaymentsForRepurchaseOfCommonStock | CY2026Q1 | USD | 1,365 filers | data.sec.gov |
| common shares outstanding (cover page) | dei:EntityCommonStockSharesOutstanding | CY2026Q2I | shares | 4,053 filers | data.sec.gov |
| public float (SEC-reported, as of the filer’s stated measurement date) | dei:EntityPublicFloat | CY2025Q2I | USD | 3,948 filers | data.sec.gov |
Source: SEC EDGAR XBRL frames (frames API), SEC company ticker/exchange file and SEC DERA SIC classifications — US-government public records. Figures are as filed; nothing here is a statement about any security's future, and reported fundamentals describe past periods only.